Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Noncash Expense
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.38M, a 27.56% decline year-over-year.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.73M, a 46.35% decline year-over-year.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.58M, a 67.93% decline year-over-year.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.52M, a 62.87% decline year-over-year.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $20.72M, a 59.97% decline from fiscal 2024.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $51.77M, a 4.73% increase from fiscal 2023.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $49.43M, a 5.80% increase from fiscal 2022.
- Atea Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $46.72M, a 17.91% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.11M 10-Q · filed 2026-08-12 | $11.70M derived: sum of 3 quarters · filed 2026-08-12 | $16.21M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $3.73M 10-Q · filed 2026-05-12 | $8.31M derived: sum of 2 quarters · filed 2026-05-12 | $12.83M derived: sum of 3 quarters · filed 2026-05-12 | $17.50M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $9.10M derived: sum of 2 quarters · filed 2026-03-05 | $13.77M derived: sum of 3 quarters · filed 2026-08-12 | $20.72M 10-K · filed 2026-03-05 |
| 2025-09-30 | $4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.18M derived: sum of 2 quarters · filed 2026-08-12 | $16.14M 10-Q · filed 2025-11-12 | $30.43M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.62M 10-Q · filed 2026-08-12 | $25.91M derived: sum of 3 quarters · filed 2026-08-12 | $38.08M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $6.95M 10-Q · filed 2026-05-12 | $21.25M derived: sum of 2 quarters · filed 2026-05-12 | $33.41M derived: sum of 3 quarters · filed 2026-05-12 | $46.13M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $26.46M derived: sum of 2 quarters · filed 2026-03-05 | $39.18M derived: sum of 3 quarters · filed 2026-03-05 | $51.77M 10-K · filed 2026-03-05 |
| 2024-09-30 | $12.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $24.88M derived: sum of 2 quarters · filed 2025-11-12 | $37.47M 10-Q · filed 2025-11-12 | $49.63M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $12.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $25.31M 10-Q · filed 2025-08-07 | $37.46M derived: sum of 3 quarters · filed 2025-08-07 | $49.85M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $12.59M 10-Q · filed 2025-05-12 | $24.74M derived: sum of 2 quarters · filed 2025-05-12 | $37.13M derived: sum of 3 quarters · filed 2025-05-12 | $49.48M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $24.54M derived: sum of 2 quarters · filed 2025-03-06 | $36.89M derived: sum of 3 quarters · filed 2025-03-06 | $49.43M 10-K · filed 2025-03-06 |
| 2023-09-30 | $12.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $24.74M derived: sum of 2 quarters · filed 2024-11-07 | $37.27M 10-Q · filed 2024-11-07 | $48.92M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $12.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $24.89M 10-Q · filed 2024-08-07 | $36.53M derived: sum of 3 quarters · filed 2024-08-07 | $48.04M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $12.54M 10-Q · filed 2024-05-14 | $24.18M derived: sum of 2 quarters · filed 2024-05-14 | $35.68M derived: sum of 3 quarters · filed 2024-05-14 | $47.59M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $23.15M derived: sum of 2 quarters · filed 2024-02-28 | $35.06M derived: sum of 3 quarters · filed 2024-02-28 | $46.72M 10-K · filed 2024-02-28 |
| 2022-09-30 | $11.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $23.41M derived: sum of 2 quarters · filed 2023-11-08 | $35.07M 10-Q · filed 2023-11-08 | $46.42M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $11.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $23.57M 10-Q · filed 2023-08-08 | $34.92M derived: sum of 3 quarters · filed 2023-08-08 | $45.91M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $11.66M 10-Q · filed 2023-05-08 | $23.01M derived: sum of 2 quarters · filed 2023-05-08 | $34.00M derived: sum of 3 quarters · filed 2023-05-08 | $44.01M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $11.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $22.34M derived: sum of 2 quarters · filed 2023-02-28 | $32.35M derived: sum of 3 quarters · filed 2023-02-28 | $39.62M 10-K · filed 2023-02-28 |
| 2021-09-30 | $10.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $21.00M derived: sum of 2 quarters · filed 2022-11-07 | $28.27M 10-Q · filed 2022-11-07 | $31.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $10.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $17.28M 10-Q · filed 2022-08-08 | $20.10M derived: sum of 3 quarters · filed 2023-02-28 | $24.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $7.27M 10-Q · filed 2022-05-10 | $10.09M derived: sum of 2 quarters · filed 2023-02-28 | $14.33M derived: sum of 3 quarters · filed 2023-02-28 | $14.54M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.06M derived: sum of 2 quarters · filed 2023-02-28 | $7.27M derived: sum of 3 quarters · filed 2023-02-28 | $7.46M 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $4.45M derived: sum of 2 quarters · filed 2021-11-12 | $4.64M 10-Q · filed 2021-11-12 | $4.81M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $398.00K 10-Q · filed 2021-08-12 | $572.00K derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-03-31 | $189.00K 10-Q · filed 2021-05-13 | $363.00K derived: sum of 2 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $624.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $450.00K 10-Q · filed 2020-12-10 | |||
| 2018-12-31 | $414.00K 10-K · filed 2021-03-30 |